Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
14. November 2026
Search
medline.ch
Oncology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 99495
Articles 1 - 20 / 1989887
A window-of-opportunity trial testing single-dose neoadjuvant hepatic arterial floxuridine and oxaliplatin for patients with localized pancreatic cancer: analysis of safety, feasibility, and interim oncologic outcomes.
HPB (Oxford)
Agritelley ES, Kanu EN, Button J, Bao M, Sannareddy DS, Fletcher AA, Skinner H, Molvin A, Rodgman M, Murray S, Chai J, Niedzwiecki D, DeVito NC, Blobe GC, Strickler JH, Hsu SD, Howard M, Abbruzzese JL, Martin AN, Zani S, Lidsky ME, Kim CY, Suhocki P, Cline B, Johnson D, Crosby EJ, Mettu NB, Mastria E, Allen PJ, Nussbaum DP.
PMID: 43026127 [PubMed - as supplied by publisher]
Corrigendum to "Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis" [Hepatobiliary Pancreat Dis Int 17 (2018) 487-495].
Hepatobiliary Pancreat Dis Int
Xing H, Zheng YJ, Han J, Zhang H, Li ZL, Lau WY, Shen F, Yang T.
PMID: 43026065 [PubMed - as supplied by publisher]
Neoadjuvant chemotherapy followed by surgery versus upfront surgery for mid-to-high rectal cancer with cT3a-bN0-1 (NESAR): study protocol for a multicentre, randomised, phase 3 trial.
BMJ Open
Cao Y, Wang S, Wang D, Wei M, Wang C, Liu Y, Qiu M, Deng X, Wang Z, Wu Q, Meng W, NESAR Study Group.
PMID: 43025953 [PubMed - in process]
CAPG beyond actin capping: Molecular regulation, cancer progression, and therapeutic resistance.
Cell Signal
Yang JW, Wang L, Zhao L, Jiao PP, Chen SY, Yang L.
PMID: 43025822 [PubMed - as supplied by publisher]
Emerging HER2-targeted treatment approaches for gastroesophageal cancer in the era of chemo-immunotherapy.
Pharmacol Ther
Friederike D, Joao G, Jan W, Alexander S, Joseph T.
PMID: 43025815 [PubMed - as supplied by publisher]
Navigating treatment for De novo oligometastatic breast cancer: The Assisi think tank meeting.
Radiother Oncol
Felice F, Pedretti S, Palumbo I, Atagun Y, Santis MC, Krengli M, Ratosa I, Coles CE, Arenas M, Boersma LJ, Marazzi F, Meattini I, Poortmans P, Aristei C, Offersen B, Kaidar-Person O, Assisi Think Tank Meeting ATTM investigators.
PMID: 43025760 [PubMed - as supplied by publisher]
Final analysis from PECATI phase 2 trial, lenvatinib in combination with pembrolizumab in pretreated advanced B3-thymoma and thymic carcinoma.
J Thorac Oncol
Remon J, Bironzo P, Girard N, Bigay-Game L, Juan-Vidal O, de Castro J, Reguart N, Greillier L, Cousin S, Dansin E, Majem M, Bernabé R, Martinez JM, Díaz M, Meya A, Alcalá-López D, García-Sanz A, Righi L, Novello S, Besse B.
PMID: 43025701 [PubMed - as supplied by publisher]
Cerebellar Mutism Syndrome After Brain Tumor Surgery in Adults: A Systematic Review and Narrative Synthesis.
World Neurosurg
Moradian R, Delfan N, Ghorbannezhad G, Abbasi F, Tabibkhooei A.
PMID: 43025631 [PubMed - as supplied by publisher]
Circulating tumor DNA to direct adjuvant immunotherapy across mismatch repair-deficient solid tumors.
Ann Oncol
Janjigian YY, Lumish MA, Foote MB, Socolow F, Perissinotto E, Darmofal M, Madwed M, Segal M, Yaqubie A, Capanu M, Chou JF, Maron SB, Ku GY, Saltz LB, Garcia-Aguilar J, Weiser MR, Konner JA, Guo R, Strong VE, Jewell E, Mueller JJ, Gu P, Yaeger R, Chalasani SB, Cercek A, Li J, Tang L, Nusrat M, Sugarman R, Jones DR, Sihag S, Desai A, Ilson D, Reidy-Lagunes D, Laszkowska M, Segal NH, Brannon AR, Loomis B, Ladanyi M, Molena D, Shia J, Berger MF, Solit DB, Diaz LA Jr.
PMID: 43025593 [PubMed - as supplied by publisher]
Bacteria-inspired drug delivery systems for cancer immunotherapy: from exploiting to mimicking.
J Control Release
Gan T, Yuan S, Wang J, Mu W, Liu Y, Zhang N.
PMID: 43025505 [PubMed - as supplied by publisher]
Antigen-specific IgG glycosylation in cancer: From tertiary lymphoid immunity toward liquid biomarkers of immunotherapy.
Clin Chim Acta
Lv C, Liu S.
PMID: 43025476 [PubMed - as supplied by publisher]
Symptom Trajectories and Subtypes in Patients With Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy: A Prospective Cohort Study.
J Adv Nurs
Hu D, Chen J, Jia Y, Pan X, Zheng Z, Li W, Bai J, Wu W, Chen X.
PMID: 43025437 [PubMed - as supplied by publisher]
Targeting F.nucleatum with metronidazole plus tislelizumab and fruquintinib in MSS colorectal cancer: A multicenter phase 2 study.
Cancer Cell
Jiang S, Lin X, Ni L, Zhang Y, Chen H, Liu C, Yuan H, Kang Z, Jiao J, Han T, Zhuo M, Wu X, Zhou J, Sun R, Hu M, Deng Z, Jiang Y, Zhang C, Xu P, Li P, Li Q, Chen YX, Xiao XY, Fang JY.
PMID: 43025422 [PubMed - as supplied by publisher]
RNA sequencing reveals molecular subtypes across adenocarcinoma, squamous, and small cell lung cancer.
Cell Genom
Arora S, Suresh L, Thirimanne NH, Glatzer G, Jensen M, Fatherree JP, Konnick EQ, Levine KM, Brooks AN, Houghton MA, Pritchard CC, MacPherson D, Berger AH, Holland EC.
PMID: 43025418 [PubMed - as supplied by publisher]
First-line treatment of gastric cancer: Five trials to watch.
Med
Narita Y, Muro K.
PMID: 43025398 [PubMed - indexed for MEDLINE]
Red-cell DNA opens new avenues for early detection of gastric cancer.
Med
Huang Y, Qian K.
PMID: 43025395 [PubMed - indexed for MEDLINE]
The promise and limitations of cell-free DNA fragmentomics for hepatocellular carcinoma surveillance.
Med
Parikh ND, Singal AG.
PMID: 43025394 [PubMed - indexed for MEDLINE]
A systematic review of barriers to mammography screening and timely breast cancer diagnosis and treatment initiation: estimating the global impact.
Cancer Epidemiol
de Azambuja E, Paluch-Shimon S, Mueller E, Neeser K, Arnold M, Napalkov P, Barrios CH.
PMID: 43025384 [PubMed - as supplied by publisher]
Characteristics and outcomes of patients with advanced or metastatic non-small cell lung cancer harboring a HER2-activating mutation: a real-world retrospective cohort study using a US clinico-genomic database.
Lung Cancer
Le X, Chouaid C, Lopez-Rios F, Duh MS, DerSarkissian M, Bernard-Gauthier V, Zong J, Vassilev Z, Lunacsek O, Lax A, Schlicker A, Chang R, Pinaire M, Chen N, Said Q.
PMID: 43025364 [PubMed - as supplied by publisher]
Ultra-Hypofractionation in Breast Cancer: A Multicenter Retrospective Cohort Study in Brazil.
Clin Breast Cancer
Marta GN, Rebouças LM, Pasquinelli PFS, de Oliveira HF, Perdigão MCL, Gondim GRM, da Silva RKGC, Hanriot RM, Alvarenga MP, Maciel GP, de Brito LH, de Oliveira RL, Gutierrez NDS, da Costa ET, Garcia VS, Hanna SA.
PMID: 43025339 [PubMed - as supplied by publisher]
Articles 1 - 20 / 1989887
Page 1 of 99495
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy